Tansu YAMAZHAN, Işıkgöz Meltem TAŞBAKAN, Özkören Şebnem ÇALIK, Önen Özen SERTÖZ, Hüsnü PULLUKÇU, Oğuz Reşat SİPAHİ

Comparison of quality of life in hepatitis B virus carriers versus chronic hepatitis B virus carriers versus the normal population

To compare health related quality of life (HRQOL) in hepatitis B virus (HBV) carriers versus chronic HBV disease carriers versus the normal population. Materials and methods: The study sample consisted of 2 groups. HBV carriers were recruited from individuals who were regularly followed-up at the Infectious Diseases and Clinical Microbiology outpatient clinic of our setting due to inactivity in HBV infection. The control group was recruited from the same outpatient clinic among patients who had a diagnosis of chronic HBV infection and who were not undergoing active treatment yet. Both groups were requested to fill in the short form 36 questionnaire on HRQOL (HRQOL-SF-36) and a form to gather data about age, gender, and education. We also compared the mean values of the SF-36 domain scores of these 2 groups with published scores of healthy controls derived from the Turkish population. Results: QOL in HBV carriers was greatly similar to that of patients with chronic HBV disease except for physical role limitation scores and both HBV carriers and patients with chronic disease had lower HRQOL than the normal Turkish population. Conclusion: When compared with the normal Turkish population, QOL is affected negatively both in chronic HBV infection patients and in HBV carriers.

Anahtar Kelimeler:

Key words: Inactive hepatitis B infection, HRQOL-SF-36, Turkey

Comparison of quality of life in hepatitis B virus carriers versus chronic hepatitis B virus carriers versus the normal population

Keywords:

Key words: Inactive hepatitis B infection, HRQOL-SF-36, Turkey,

PDF

___

Niederau C, Fischer C, Kautz A. Socio-economical aspects, quality of life and state of knowledge in hepatitis B patients. Soci-economical aspects in hepatitis B. Z Gastroenterol 2007; 45: 355-68.
Younossi ZM, Guyatt G. Quality of life assessments in chronic liver disease. Am J Gastroenterol 1998; 93: 1037-41.
Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209-12.
Tarlov AR, Ware JE Jr, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The Medical Outcomes Study. An application of methods for monitoring the results of medical care. JAMA 1989; 262: 925-30.
Ware JE JR, Sherbourne CD. The MOS 36- item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29:264-70.
Iwasaki M, Kanda D, Toyoda M, Yuasa K, Hashimoto Y, Takagi H et al. Absence of specific symptoms in chronic hepatitis C. J Gastroenterol 2002; 37: 709-16.
Yi LX, Yang X, Wang XW. Effect of Lamivudine treatment on the quality of life of chronic hepatitis B. Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006; 31: 396-9.
Lok ASF, McMahon BJ. AASLD practise guidelines: chronic hepatitis B: update of recommendations. Hepatology 2004; 39:1- 5.
Keeffe EB, Dieterich DT, Han SH, Jacobson IM, Martin P, Schiff ER et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States. Clin Gastroenterol Hepatol 2004; 2: 87-106.
Demiral Y, Ergör G, Ünal B, Semin S, Akvardar Y, Kıvırcık B et al. Normative data and discriminative properties of short form 36 (SF-36) in Turkish urban population. BMC Public Health. 2006; 6: 247-54
Koçyiğit H, Aydemir O, Ölmez N, Memiş A. Kisa Form-36’nin Türkçe Versiyonunun Güvenirliği ve Geçerliliği. İlaç ve Tedavi Dergisi 1999; 12: 102-6.
Sharif F, Mohebbi S, Tabatabaee HR, Firoozi MS, Gholamzadeh S. Effects of psycho-educational intervention on health-related quality of life (QOL) of patients with chronic liver disease referring to Shiraz University of Medical Sciences. Health Qual Life Outcomes 2005; 3: 81.
Balcıoğlu I, Özdemir S. Neuropsychiatric symptoms associated with chronic hepatitis. In: Viral Hepatit 2005. Tabak F, Balık I, Tekeli E, editors. İstanbul: Ohan Matbaası, 2005. p. 76-82.
Caylan R. Chronic Hepatitis and quality life. In: Viral Hepatit 2007. Tabak F, Balık I, Tekeli E, editors. İstanbul: Ohan Matbaası, 2006. p. 376-82.
Özkan M, Çorapçıoğlu A, Balcıoğlu I, Ertekin E, Khan S, Özdemir S et al. Psychiatric morbidity and its effect on the quality of life of patients with chronic hepatitis B and hepatitis C. Int J Psychiatry Med 2006; 36: 283-97.
Hussain KB, Fontana RJ, Moyer CA, Su GL, Sneed-Pee N, Lok AS. Comorbid illness is an important determinant of health- related quality of life in patients with chronic hepatitis C. Am J Gastroenterol 2001; 96: 2734-44.
Bao ZJ, Qiu DK, Ma X, Fan ZP, Zhang GS, Huang YQ, Yu XF, Zeng MD. Assessment of health-related quality of life in Chinese patients with minimal hepatic encephalopathy. World J Gastroenterol 2007; 13: 3003-8.
Pınar R. Reliability and construct validity of the SF-36 in Turkish cancer patients. Qual Life Res 2005; 14: 259-64.
Bayliss MS, Gandek B, Bungay KM, Sugano D, Hsu MA, Ware JE Jr. A questionnaire to assess the generic and disease-specific health outcomes of patients with chronic hepatitis C. Qual Life Res 1998; 7: 39-55.
Wu GC, Zhou WP, Zhao YR, Guo SH, Wang ZY, Zou SB et al. Long-term health-related quality of life in chronic hepatitis B patients. Zhonghua Gan Zang Bing Za Zhi 2003; 11: 275-7.